Canada markets closed

NextCure, Inc. (2US.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.4160-0.0760 (-5.09%)
At close: 08:22AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 40.07M
Enterprise Value -55.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.39
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.87

Trading Information

Stock Price History

Beta (5Y Monthly) 0.39
52-Week Change 312.18%
S&P500 52-Week Change 322.64%
52 Week High 32.2750
52 Week Low 30.9600
50-Day Moving Average 31.5649
200-Day Moving Average 31.2998

Share Statistics

Avg Vol (3 month) 3129
Avg Vol (10 day) 3N/A
Shares Outstanding 527.9M
Implied Shares Outstanding 628.4M
Float 820.77M
% Held by Insiders 18.84%
% Held by Institutions 150.25%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.08%
Return on Equity (ttm)-44.49%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -63.95M
Net Income Avi to Common (ttm)-62.72M
Diluted EPS (ttm)-2.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)108.3M
Total Cash Per Share (mrq)3.88
Total Debt (mrq)6.61M
Total Debt/Equity (mrq)5.77%
Current Ratio (mrq)16.38
Book Value Per Share (mrq)4.10

Cash Flow Statement

Operating Cash Flow (ttm)-52.97M
Levered Free Cash Flow (ttm)-33.96M